Drugs Made In America Acquisition II Ownership | Who Owns Drugs Made In America Acquisition II?


OverviewFinancialsChart

Drugs Made In America Acquisition II Ownership Summary


Drugs Made In America Acquisition II is owned by 86.41% institutional investors, 15.22% insiders. Mmcap inc. spc is the largest institutional shareholder, holding 20.32% of DMII shares.

DMII Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDrugs Made In America Acquisition II86.41%15.22%-1.63%
IndustryShell Companies Stocks 2778.81%20.40%-2699.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Mmcap inc. spc2.70M20.32%$26.92M
Magnetar financial2.70M20.32%$26.95M
Karpus management2.60M19.55%$25.90M
Glazer capital2.35M17.68%$23.43M
Healthcare of ontario pension plan trust fund2.00M15.05%$19.96M
Millennium management1.98M14.87%$19.70M
Hudson bay capital management lp1.97M14.82%$19.65M
Wolverine asset management1.80M13.51%$17.90M
Tenor capital management1.50M11.29%$14.96M
Polar asset management partners1.50M11.29%$14.96M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mercuria capital strategies750.00K2.86%$7.48M
Hgc investment management1.23M2.72%$12.27M
Mmcap inc. spc2.70M2.32%$26.92M
Heights capital management519.40K1.44%$5.18M
Wealthspring capital402.67K0.95%$4.01M
Karpus management2.60M0.81%$25.90M
Crossingbridge advisors350.00K0.63%$3.49M
First trust capital management1.07M0.56%$10.65M
Glazer capital2.35M0.50%$23.43M
Radcliffe capital management575.72K0.43%$5.74M

Top Buyers

HolderShares% AssetsChange
Mmcap inc. spc2.70M2.32%2.70M
Healthcare of ontario pension plan trust fund2.00M0.03%2.00M
Karpus management2.60M0.81%1.45M
Mercuria capital strategies750.00K2.86%750.00K
Wolverine asset management1.80M0.17%732.52K

Top Sellers

HolderShares% AssetsChange
First trust capital management1.07M0.56%-1.00M
Css llc/il110.04K0.05%-695.96K
Mizuho securities usa18.60K0.00%-197.71K
Clear street group15.35K0.00%-166.18K
Cable car capital---100.00K

New Positions

HolderShares% AssetsChangeValue
Mmcap inc. spc2.70M2.32%2.70M$26.92M
Healthcare of ontario pension plan trust fund2.00M0.03%2.00M$19.96M
Mercuria capital strategies750.00K2.86%750.00K$7.48M
Heights capital management519.40K1.44%519.40K$5.18M
Bluecrest capital management500.00K0.29%500.00K$4.99M

Sold Out

HolderChange
Cable car capital-100.00K
Quarry lp-100.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202619-62.75%11,482,051-66.93%860.01%6-88.24%6-
Dec 31, 202551-34,724,554-1,277-51---

DMII Ownership FAQ


Who Owns Drugs Made In America Acquisition II?

Drugs Made In America Acquisition II shareholders are primarily institutional investors at 86.41%, followed by 15.22% insiders and -1.63% retail investors. The average institutional ownership in Drugs Made In America Acquisition II's industry, Shell Companies Stocks , is 2778.81%, which Drugs Made In America Acquisition II falls below.

Who owns the most shares of Drugs Made In America Acquisition II?

Drugs Made In America Acquisition II’s largest shareholders are Mmcap inc. spc (2.7M shares, 20.32%), Magnetar financial (2.7M shares, 20.32%), and Karpus management (2.6M shares, 19.55%). Together, they hold 60.19% of Drugs Made In America Acquisition II’s total shares outstanding.

Does Blackrock own Drugs Made In America Acquisition II?

BlackRock is not among the top 10 institutional shareholders of Drugs Made In America Acquisition II.

Who is Drugs Made In America Acquisition II’s biggest shareholder by percentage of total assets invested?

Mercuria capital strategies is Drugs Made In America Acquisition II’s biggest shareholder by percentage of total assets invested, with 2.86% of its assets in 750K Drugs Made In America Acquisition II shares, valued at 7.48M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools